EICHOR
● Active Not Recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Condition: Carcinoma, Non-Small-Cell Lung · Colorectal Neoplasms · Endometrial Neoplasms · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients must have already received or were not able to tolerate the standard of care, except for specific groups who have not had cancer treatment. The study will last up to approximately 4 years.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (49)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| USC Norris Cancer Hospital | Los Angeles, California, United States | — |
| Chao Family Comprehensive Cancer Ctr. | Orange, California, United States | — |
| Yale-New Haven Hospital | New Haven, Connecticut, United States | — |
| AdventHealth Orlando | Orlando, Florida, United States | — |
| Florida Cancer Specialists | Sarasota, Florida, United States | — |
| Indiana Univ Melvin & Bren Simon Cancer Center | Indianapolis, Indiana, United States | — |
| Community Health Network | Indianapolis, Indiana, United States | — |
| Mary Bird Perkins Cancer Center | Baton Rouge, Louisiana, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire, United States | — |
| NYU Langone Health- Long Island | Mineola, New York, United States | — |
+ 37 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04956640